**Page:** 15

<!-- page break -->
A reconciliation of the Company's segment operating income to the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 30, 2024 and April 1, 2023 is as follows (in millions):

|                                  | Three Months Ended   | Three Months Ended   | Six Months Ended   | Six Months Ended   |
|----------------------------------|----------------------|----------------------|--------------------|--------------------|
|                                  | March 30, 2024       | April 1, 2023        | March 30, 2024     | April 1, 2023      |
| Segment operating income         | $ 37,706             | $ 37,488             | $ 87,794           | $ 82,893           |
| Research and development expense | (7,903)              | (7,457)              | (15,599)           | (15,166)           |
| Other corporate expenses, net    | (1,903)              | (1,713)              | (3,922)            | (3,393)            |
| Total operating income           | $ 27,900             | $ 28,318             | $ 68,273           | $ 64,334           |